The in vitro diagnostics market globally generated revenue of about USD 108.30 billion in 2024 and is projected to grow to approximately USD 150.13 billion by 2030, expanding at a CAGR of 5.62% from 2025 to 2030. Increasing reliance on rapid, accurate, and individualized diagnostic solutions continues to fuel market growth across healthcare settings.
The global hair care market is entering a transformative stage driven by rising consumer awareness, evolving lifestyles, and a strong focus on personal grooming. According to recent projections, the market is expected to reach $121.08 billion by 2032, expanding at a steady CAGR of 4.1% from 2025 to 2032.
The global transplant diagnostics market was valued at approximately USD 6.84 billion in 2025 and is expected to grow to USD 12.15 billion by 2033, reflecting a compound annual growth rate (CAGR) of 7.45% during 2025-2033.
The global anesthesia and respiratory devices market was valued at approximately USD 59.3 billion in 2025 and is projected to reach USD 91.5 billion by 2033, showing a compound annual growth rate (CAGR) of 5.6% between 2025 and 2033.
The global preparative and process chromatography market was valued at approximately USD 13.78 billion in 2025 and is forecast to grow to USD 21.15 billion by 2033, corresponding to a compound annual growth rate (CAGR) of 5.50%.
The global market for gene synthesis dedicated to research use reached an estimated USD 2.42 billion in 2025, with projections indicating growth to USD 8.39 billion by 2033. This expansion is powered by a 16.8% CAGR, primarily driven by surging investments in synthetic biology and ongoing advances in gene synthesis methods.
The advanced cancer diagnostics market in the Middle East reached an estimated valuation of USD 1.43 billion in 2025, with robust projections targeting USD 2.51 billion by 2033. This rapid expansion is underpinned by a compound annual growth rate (CAGR) of 7.3%, driven by increasing cancer incidence, urgency for early and accurate detection, ongoing technology upgrades, and far-reaching modernization in healthcare systems across Saudi Arabia, UAE, Kuwait, Oman, Qatar, and surrounding regions.
The global point-of-care influenza diagnostics market reached approximately USD 440.47 million in 2025 and is expected to grow to USD 709.52 million by 2033, at a CAGR of 6.14% during the period from 2025 to 2033. Key growth drivers include increased prevalence and severity of seasonal and zoonotic influenza outbreaks, rapid adoption of decentralized testing, technological innovation in diagnostics, and integration with telehealth and home-based healthcare solutions.
The Latin America energy-based aesthetic devices market was valued at approximately USD 378.5 million in 2025 and is expected to grow to USD 638.0 million by 2033, registering a compound annual growth rate (CAGR) of 6.7% between 2025 and 2033.
The Middle East & Africa (MEA) wound wash market was valued at approximately USD 2.26 billion in 2025, expected to reach USD 3.76 billion by 2033, growing at a compound annual growth rate (CAGR) of 6.59% from 2025 to 2033. Market expansion is attributed to increasing prevalence of chronic and acute wounds like diabetic ulcers and surgical injuries, alongside improved healthcare infrastructure and accessibility across the region.